<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Молодежный инновационный вестник</journal-id><journal-title-group><journal-title>Молодежный инновационный вестник</journal-title></journal-title-group><issn publication-format="print">2415-7805</issn><publisher><publisher-name>Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный медицинский университет имени Н.Н. Бурденко" Министерства здравоохранения Российской Федерации</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">11185</article-id><article-categories><subj-group subj-group-type="heading"><subject>Conference Proceedings</subject></subj-group></article-categories><title-group><article-title>Ratios of complete blood test in screening, diagnostics and prognosis of tuberculosis</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Brekhova</surname><given-names>Anna Sergeevna</given-names></name><bio>&lt;p&gt;&amp;mdash;&lt;/p&gt;</bio><email>as.brekhova@yandex.ru</email><uri content-type="orcid">https://orcid.org/0009-0007-4155-3137</uri><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kaluzhenina</surname><given-names>Anna Andreevna</given-names></name><bio>&lt;p&gt;Candidate of Medical Sciences, Associate Professor of the Department of Phthisiopulmonology&lt;/p&gt;</bio><email>peace81.81@mail.ru</email><uri content-type="orcid">https://orcid.org/0000-0002-0771-1951</uri><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">Volgograd State Medical University</aff><pub-date date-type="epub" iso-8601-date="2026-10-01" publication-format="electronic"><day>01</day><month>10</month><year>2026</year></pub-date><volume>15</volume><issue>S1</issue><fpage>677</fpage><lpage>679</lpage><history><pub-date date-type="received" iso-8601-date="2026-02-23"><day>23</day><month>02</month><year>2026</year></pub-date><pub-date date-type="accepted" iso-8601-date="2026-04-11"><day>11</day><month>04</month><year>2026</year></pub-date></history><permissions><copyright-statement>Copyright © 2026, Brekhova A.S., Kaluzhenina A.A.</copyright-statement><copyright-year>2026</copyright-year></permissions><abstract>&lt;p style="text-align: justify;"&gt;The ratios of monocytes to lymphocytes (MLR), neutrophils to lymphocytes (NLR), and platelets to lymphocytes (PLR) are markers of inflammation that are already used in oncology and cardiology, but are expected to be used in infection diseases, especially, in tuberculosis. The aim. To analyze data on MLR, NLR, and PLR in patients with tuberculosis. Materials and methods. The data from meta-analyses and scientific articles containing the results of cohort studies were analyzed. Results. The MLR has already recommended itself as a predictive tool for assessing the quality of TB-therapy. Further research is needed to evaluate the marker as a screening measure. The NLR can be used in the differential diagnostics of tuberculosis and community-acquired bacterial pneumonia. Further studies are required to evaluate the marker as a predictive tool for the development of latent or active tuberculosis, especially in people at risk. There are little data of PLR and its correlation in tuberculosis to draw conclusions about its use in screening, diagnostics, and prognosis of treatment. Conclusions. Despite the simplicity of obtaining these laboratory ratios, more research is needed in different populations to use MLR, NLR, and PLR for screening, diagnostics, and prognosis of tuberculosis outcome.&lt;/p&gt;</abstract><kwd-group xml:lang="en"><kwd>tuberculosis</kwd><kwd>monocyte-to-lymphocyte ratio</kwd><kwd>neutrophil-to-lymphocyte ratio</kwd><kwd>platelets-to-lymphocyte ratio</kwd><kwd>complete blood test</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>туберкулёз</kwd><kwd>соотношение моноцитов к лимфоцитам</kwd><kwd>соотношение нейтрофилов к лимфоцитам</kwd><kwd>соотношение тромбоцитов к лимфоцитам</kwd><kwd>общий анализ крови</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Wang W, Wang LF, Liu YY, Yang F, Zhu L, Zhang XH. Value of the Ratio of Monocytes to Lymphocytes for Monitoring Tuberculosis Therapy. Can J Infect Dis Med Microbiol. 2019;2019:3270393. Published 2019 May 27. doi:10.1155/2019/3270393</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Adane T, Melku M, Ayalew G, Bewket G, Aynalem M, Getawa S. Accuracy of monocyte to lymphocyte ratio for tuberculosis diagnosis and its role in monitoring anti-tuberculosis treatment: Systematic review and meta-analysis. Medicine (Baltimore). 2022;101(44):e31539. doi:10.1097/MD.0000000000031539</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Mayito J, Meya DB, Miriam A, Dhikusooka F, Rhein J, Sekaggya-Wiltshire C. Monocyte to Lymphocyte ratio is highly specific in diagnosing latent tuberculosis and declines significantly following tuberculosis preventive therapy: A cross-sectional and nested prospective observational study. PLoS One. 2023;18(11):e0291834. Published 2023 Nov 30. doi:10.1371/journal.pone.0291834</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Miyahara R, Piyaworawong S, Naranbhai V, et al. Predicting the risk of pulmonary tuberculosis based on the neutrophil-to-lymphocyte ratio at TB screening in HIV-infected individuals. BMC Infect Dis. 2019;19(1):667. Published 2019 Jul 29. doi:10.1186/s12879-019-4292-9</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Yoon NB, Son C, Um SJ. Role of the neutrophil-lymphocyte count ratio in the differential diagnosis between pulmonary tuberculosis and bacterial community-acquired pneumonia. Ann Lab Med. 2013;33(2):105-110. doi:10.3343/alm.2013.33.2.105</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Berhane M, Melku M, Amsalu A, Enawgaw B, Getaneh Z, Asrie F. The Role of Neutrophil to Lymphocyte Count Ratio in the Differential Diagnosis of Pulmonary Tuberculosis and Bacterial Community-Acquired Pneumonia: a Cross-Sectional Study at Ayder and Mekelle Hospitals, Ethiopia. Clin Lab. 2019;65(4):10.7754/Clin.Lab.2018.180833. doi:10.7754/Clin.Lab.2018.180833</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Huang Y, Ao T, Zhen P, Hu M. Neutrophil-to-lymphocyte ratio and its association with latent tuberculosis infection and all-cause mortality in the US adult population: a cohort study from NHANES 2011-2012. Front Nutr. 2024;11:1467824. Published 2024 Oct 3. doi:10.3389/fnut.2024.1467824</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Qitian He, Wenjun Tang, Yan Deng, Yu He, Li Xie, Xue Qin, Shan Li. The diagnostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in tuberculous spondylitis. Int J Clin Exp Med 2016;9(8):16360-16366.</mixed-citation></ref></ref-list></back></article>
